The State of Texas Top Legal Officer Files Lawsuit Against Tylenol Manufacturers Regarding Autism Allegations

The top legal official in Texas Paxton is taking legal action against the manufacturers of Tylenol, asserting the firms concealed safety concerns that the pain reliever presented to pediatric brain development.

The court filing follows thirty days after President Donald Trump promoted an unverified association between using acetaminophen - alternatively called acetaminophen - during pregnancy and autism spectrum disorder in children.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the medication, the sole analgesic recommended for women during pregnancy, and Kenvue, which now manufacturers it.

In a declaration, he claimed they "deceived the public by gaining financially from pain and pushing pills ignoring the risks."

Kenvue says there is insufficient reliable data connecting Tylenol to autism spectrum disorder.

"These corporations lied for decades, deliberately risking countless individuals to boost earnings," Paxton, from the Republican party, said.

The company commented that it was "very worried by the dissemination of inaccurate information on the security of paracetamol and the possible consequences that could have on the well-being of American women and children."

On its online platform, Kenvue also mentioned it had "continuously evaluated the relevant science and there is insufficient valid information that shows a established connection between using paracetamol and autism spectrum disorder."

Associations acting on behalf of doctors and medical practitioners agree.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in acetaminophen - is one of the few options for women during pregnancy to manage pain and elevated temperature, which can present significant medical dangers if left untreated.

"In multiple decades of investigation on the use of acetaminophen in pregnancy, zero credible investigations has definitively established that the consumption of acetaminophen in any stage of pregnancy leads to neurodevelopmental disorders in young ones," the organization commented.

This legal action cites latest statements from the former administration in claiming the drug is potentially dangerous.

In recent weeks, Trump caused concern from health experts when he instructed women during pregnancy to "struggle intensely" not to use acetaminophen when unwell.

The US Food and Drug Administration then released a statement that doctors should think about restricting the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who supervises the FDA, had vowed in spring to undertake "comprehensive study program" that would identify the origin of autism spectrum disorder in a limited time.

But experts advised that discovering a sole reason of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a form of lifelong neurodivergence and condition that influences how people experience and interact with the environment, and is diagnosed using medical professional evaluations.

In his legal document, Paxton - a Trump ally who is running for US Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the research" around paracetamol and autism.

The case seeks to make the corporations "eliminate any promotional materials" that claims Tylenol is secure for expectant mothers.

The court case mirrors the grievances of a assembly of parents of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in two years ago.

The court rejected the legal action, stating investigations from the parents' expert witnesses was inconclusive.